Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

BUY
$269.37 - $365.04 $7,542 - $10,221
28 Added 127.27%
50 $16,000
Q3 2023

Nov 13, 2023

SELL
$350.25 - $422.63 $5,604 - $6,762
-16 Reduced 42.11%
22 $7,000
Q2 2023

Aug 08, 2023

BUY
$359.49 - $486.4 $5,032 - $6,809
14 Added 58.33%
38 $14,000
Q1 2023

May 04, 2023

BUY
$418.69 - $503.0 $2,512 - $3,018
6 Added 33.33%
24 $11,000
Q4 2022

Feb 06, 2023

BUY
$351.71 - $456.01 $351 - $456
1 Added 5.88%
18 $7,000
Q3 2022

Nov 09, 2022

BUY
$412.59 - $563.26 $2,475 - $3,379
6 Added 54.55%
17 $7,000
Q2 2022

Aug 04, 2022

SELL
$463.67 - $597.16 $1,391 - $1,791
-3 Reduced 21.43%
11 $5,000
Q1 2022

Aug 23, 2022

BUY
$524.57 - $735.42 $1,049 - $1,470
2 Added 16.67%
14 $8,000
Q1 2022

Apr 14, 2022

BUY
$524.57 - $735.42 $524 - $735
1 Added 9.09%
12 $7,000
Q4 2021

Feb 14, 2022

BUY
$708.84 - $794.68 $6,379 - $7,152
9 Added 450.0%
11 $8,000
Q2 2021

Aug 04, 2021

BUY
$576.64 - $649.04 $576 - $649
1 Added 100.0%
2 $1,000
Q1 2021

May 05, 2021

BUY
$547.01 - $662.35 $547 - $662
1 New
1 $1,000
Q1 2020

May 12, 2020

SELL
$320.01 - $409.07 $3,200 - $4,090
-10 Closed
0 $0
Q3 2019

Nov 01, 2019

SELL
$304.55 - $345.24 $609 - $690
-2 Reduced 16.67%
10 $3,000
Q2 2019

Aug 08, 2019

SELL
$286.93 - $312.59 $573 - $625
-2 Reduced 14.29%
12 $4,000
Q1 2019

May 10, 2019

SELL
$224.3 - $317.41 $448 - $634
-2 Reduced 12.5%
14 $4,000
Q4 2018

Feb 06, 2019

SELL
$220.1 - $309.0 $440 - $618
-2 Reduced 11.11%
16 $4,000
Q3 2018

Nov 13, 2018

SELL
$289.28 - $326.15 $867 - $978
-3 Reduced 14.29%
18 $6,000
Q2 2018

Aug 09, 2018

SELL
$244.1 - $303.88 $732 - $911
-3 Reduced 12.5%
21 $6,000
Q1 2018

May 01, 2018

BUY
$233.97 - $274.11 $5,615 - $6,578
24 New
24 $6,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.37B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Glassman Wealth Services Portfolio

Follow Glassman Wealth Services and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glassman Wealth Services, based on Form 13F filings with the SEC.

News

Stay updated on Glassman Wealth Services with notifications on news.